Why Panbela Therapeutics (PBLA) Stock Is Nosediving


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


Panbela Therapeutics Inc (NASDAQ:PBLA) shares are trading lower by 26% to $0.70 Friday morning. The stock is moving sharply lower after the company announced that it reached agreements with certain holders of its warrants, allowing them to exercise these warrants for 2.13 million shares of its common stock at a reduced price of 78 cents per share.

This will result in approximately $1.9 million in gross proceeds, excluding financial advisory fees. The reduction in exercise price and issuance of new warrants comply with Nasdaq rules and were facilitated with the assistance of Roth Capital Partners as the company's financial advisor.

According to data from Benzinga Pro, PBLA has a 52-week high of $295.50 and a 52-week low of $0.70.


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsPenny Stockswhy it's moving